Imagion Biosystems Ltd: Re-instatement to Official Quotation Imminent
Imagion Biosystems Ltd: Appendix 4G and Corporate Governance Statement
Imagion Biosystems Ltd: Final Director's Interest Notice
Imagion Biosystems Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Imagion Biosystems Ltd: Imagion Business Update
Imagion Biosystems Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Imagion Biosystems Ltd: Final Director's Interest Notice - Dr. Isaac Bright
Imagion Biosystems Ltd: Imagion Announces Positive Results from Phase 1 Study
Imagion Biosystems Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Imagion Biosystems Ltd: Phase 1 Study Closure and Preliminary Performance
Imagion Biosystems Ltd: Imagion presents ovarian cancer data at AACR conference
Imagion Biosystems Ltd: Investor update
Imagion Biosystems Ltd: 2022 R&D Tax Refund
Imagion Biosystems Ltd: Convertible Note Investment
Imagion Biosystems Ltd: MOU to develop early pancreatic cancer diagnosis platform
Imagion Biosystems Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Imagion Biosystems Ltd: Transition of Chairman
Imagion Biosystems Ltd: Response to ASX Price Query
Imagion Biosystems Ltd: Expanded collaboration with Siemens Healthineers to US
Imagion Biosystems Ltd: Imagion to complete the MagSense HER2 Phase 1 Study
No Data